This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sigma Labs, Inc. Obtains Exclusive Patent Rights For Advanced Dental Implant Technology

SANTA FE, N.M., Nov. 14, 2013 /PRNewswire/ -- Sigma Labs, Inc. (OTCBB: SGLB) announced today that it has obtained the complete assignment interest in its critical patent on advanced dental implant technology thereby enabling commercialization to proceed unencumbered.  This supports Sigma Labs exclusive marketing agreement (EMA) with Manhattan Scientifics, Inc. ( http://mhtx.com).  The EMA sets forth the parties intent to market Sigma Labs technology to prospective licensees and strategic partners.  The Sigma Labs rapid healing implant uses former U.S. National Laboratory technology to create a surface that can completely integrate with bone in four to six weeks, with attendent reduction of inflamation and patient discomfort. 

Mark Cola, President and Chief Executive Officer of Sigma Labs, stated that, "In an continuing effort to monetize our full IP portfolio while maintaining focus on our efforts in PrintRite3D ® for metal 3D printing, we are pleased to work with Manhattan Scientifics to identify prospective licensees and strategic partners for our advanced dental implant technology.  Manhattan Scientifics has a similar heritage of commercializing advanced technology from leading U.S. national research institutions." 

Manny Tsoupanarias, Chief Executive Officer of Manhattan Scientifics further stated that, "We are pleased to have the opportunity to market Sigma Labs dental technology.  We feel this technology may be very attractive to the global dental implant market and potentially other implants as well. We plan to leverage our previous work and contacts within the industry to create new opportunities for both of our companies." Manny Tsoupanarias continued that "Sigma Labs technology is entirely in line with our focus on nano-medicine technologies and augments our previous work in nanomaterials for dental implants."

About Sigma Labs, Inc. Sigma Labs, Inc., through its wholly-owned subsidiary B6 Sigma, Inc., develops and engineers advanced non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for 3D metal printing and other advanced manufacturing technologies.  Sigma Labs' other wholly-owned subsidiary, Sumner & Lawrence Limited, provides high-level scientific consultants to Federal government clients seeking productive solutions for emerging and strategic development technologies. For more information please visit us at www.sigmalabsinc.com

Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 .  Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.

Mark Cola, President and CEO of Sigma Labs, Inc., +1-505-438-2576

SOURCE Sigma Labs, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs